Evaluating direct oral anticoagulant candidacy and pharmacist-led conversion of eligible patients on vitamin K antagonist to direct oral anticoagulants

Although most patients in both anticoagulation clinics remained on VKA therapy, a large proportion of patients were eligible to convert to DOACs. This study provides a framework for pharmacist-led VKA to DOAC conversions, which can be conducted on an annual basis.